Market Tracker

07/26 7:58am ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

4.02
Delayed Data
As of Jul 25
 +0.05 / +1.26%
Today’s Change
1.45
Today|||52-Week Range
4.37
+22.56%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close3.97
Today’s open4.05
Day’s range3.77 - 4.19
Volume738,250
Average volume (3 months)191,998
Market cap$177.8M
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)-269.23%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.38%
P/E ratioNM
Price/Sales44.43
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARGSArgos Therapeutics I...-0.40-5.87%
NBRVNabriva Therapeutics...-0.03-0.36%
RGLSRegulus Therapeutics...+0.03+0.87%
ATHXAthersys Inc0.000.00%
Data as of 07/25/2016

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.8M
Annual profit (last year)-$17.9M
Net profit margin-647.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer &
Secretary
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts